Article
Reovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysis.
Journal of virology - 1 Jul 2012
Shmulevitz Maya, Gujar Shashi A, Ahn Dae-Gyun, Mohamed Adil, Lee Patrick W K
Abstract excerpt
Reovirus preferentially replicates in transformed cells and is being explored as a cancer therapy. Immunological and physical barriers to virotherapy inspired a quest for reovirus variants with enhanced oncolytic potency. Using a classical genetics approach, we isolated two reovirus variants (T3v1 and T3v2) with superior replication relative to wild-type reovirus serotype 3 Dearing (T3wt) on various human and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
